Back to search
FDAFDA · Food and drugs·Recall number D-0614-2017

Fluconazole Injection, USP, 400 mg in 200 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-003-06

Published April 5, 2017 · Recall initiated: March 10, 2017

Summary

FDA records drug Class II recall D-0614-2017, published April 5, 2017 and initiated March 10, 2017. Recalling firm: Claris Lifesciences Inc; Status: Terminated; Reported quantity: 18,096 units (3016 cartons x 6 bags); Lot: Lot #: A051052, Exp. Aug 2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Claris Lifesciences Inc
Distributor
Nationwide
Lot
Lot #: A051052, Exp. Aug 2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fluconazole Injection, USP, 400 mg in 200 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-003-06 recalled?

Yes. FDA published recall D-0614-2017 on April 5, 2017. Reported hazard: Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter